"In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced today that the prime-boost investigational vaccine regimen was safe and 31 percent effective in preventing HIV infection."
Read more in AIDS.gov, September 24, 2009.
Note: See 3 articles on this study today in AIDSMAP (dated 24.09.09).
0 comments:
Post a Comment